Probiotics: A practical review of their role in specific clinical scenarios

Nutrition in Clinical Practice

Volumn 20, Issue 2, 2005, Pages 262-270

  Jenkins, Barry ^a   Holsten, Steven ^b   Bengmark, Stig ^c   Martindale, Robert ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO; PREBIOTIC AGENT; PROBIOTIC AGENT; RIFAXIMIN; SALAZOSULFAPYRIDINE; UNCLASSIFIED DRUG; VSL 3;

CLINICAL TRIAL; CROHN DISEASE; DIARRHEA; DRUG MECHANISM; DRUG MIXTURE; DRUG TOLERANCE; ENTERITIS; HUMAN; ILEITIS; ILEOANAL ANASTOMOSIS; LACTOBACILLUS PLANTARUM; LIVER TRANSPLANTATION; PANCREATITIS; REVIEW; SACCHAROMYCES BOULARDII; DIGESTIVE SYSTEM DISEASE; IMMUNOLOGY; MICROBIOLOGY; POSTOPERATIVE COMPLICATION;

LACTOBACILLUS PLANTARUM; SACCHAROMYCES BOULARDII;

DIARRHEA; DIGESTIVE SYSTEM DISEASES; HUMANS; INFLAMMATORY BOWEL DISEASES; LIVER TRANSPLANTATION; PANCREATITIS; POSTOPERATIVE COMPLICATIONS; PROBIOTICS;

EID: 27744518530     PISSN: 08845336     EISSN: None     Source Type: Journal    
DOI: 10.1177/0115426505020002262     Document Type: Review

References (63)

1. Collins MD, Gibson GR. Probiotics, prebiotics, and synbiotics: approaches for modulating the microbial ecology of the gut. Am J Clin Nutr. 1999;69(suppl):1052S-1057S.
2. Matarese LE, Seidner DL, Steiger E. The role of probiotics in gastrointestinal disease. Nutr Clin Pract. 2003;18:507-516.
3. Bengmark S. Gut microbial ecology in critical illness: is there a role for prebiotics, probiotics, and synbiotics? Curr Opin Crit Care. 2002;8:145-151.
4. Brandtzaeg P, Halstensen TS, Kett K, et al. Immunobiology and immunopathology of human gut mucosa: humoral immunity and intraepithelial lymphocytes. Gastroenterology. 1989;97:1562-1584.
5. Shirabe K, Matsumata T, Shimada T, et al. A comparison of parenteral hyperalimentation and early enteral feeding regarding systemic immunity after major hepatic resection: the result of a randomized prospective study. Hepatogastroenterology. 1997;44: 205-209.
6. Windsor AC, Kanwar S, Li AG, et al. Compared with parenteral nutrition, enteral feeding attenuates the acute phase response, and improves disease severity in acute pancreatitis. Gut. 1998;42: 431-435.
7. Roszkowski K, Ko KL, Beuth J, et al. Intestinal microflora of BALB/c-mice and function of local immune cells. Zeitschrift Bakteriologie Hygien. 1988;270:270-279.
8. Pulverer G, Ko HL, Roszkowski W, Beuth J, Yassin A, Jeljaszewicz J. Digestive tract microflora liberates low molecular weight peptides with immunotriggering activity. Zentralblatt Bakteriologie. 1990;272:318-327.
9. Kilcullen JK, Ly OP, Chang TH, Levenson SM, Steinberg JJ. Nonviable Staphylococcus aureus and its peptidoglycan stimulate macrophage recruitment, angiogenesis, fibroplasia and collagen accumulation in wounded rats. Wound Repair Regen. 1998;6:149-156.
10. Hatcher GE, Lamprecht RS. Augmentation of macrophage phagocytic activity by cell-free extracts of selected lactic acid-producing bacteria. J Dairy Sci. 1993;76:2485-2492.
11. Mangell P, Nejdfors P, Wang M, et al. Lactobacillus plantarum 299v inhibits Escherichia coli-induced intestinal permeability. Dig Dis Sci. 2002;47:511-516.
12. Delzenne N, Cherbut C, Neyrinck A. Prebiotics: actual and potential effects in inflammatory and malignant colonic diseases. Curr Opin Clin Nutr Metab Care. 2003;6:581-586.
13. Bergmark S, Martindale R. Prebiotics and synbiotics in clinical medicine. Nutr Clin Pract. 2005;20:244-261.
14. Sartor RB. Enteric microflora in IBD: pathogens or commensals? Inflamm Bowel Dis. 1997;3:230-235.
15. Giaffer MH, Holdsworth CD, Duerden BI. The assessment of faecal flora in patients with inflammatory bowel disease by a simplified bacteriological technique. J Med Microbiol. 1991;35: 238-243.
16. Plein K, Hotz J. Therapeutic effects of Saccharomyces boulardii on mild residual symptoms in a stable phase of Crohn's disease with special respect to chronic diarrhea: a pilot study. Z Gastroenterol. 1993;31:129-134.
17. Malchow HA. Crohn's disease and Escherichia coli: a new approach in therapy to maintain remission of colonic Crohn's disease? J Clin Gastroenterol. 1997;25:653-658.
18. Guslandi M, Mezzi G, Sorghi M, Testoni PA. Saccharomyces boulardii in maintenance treatment of Crohn's disease. Dig Dis Sci. 2000;45:1462-1464.
19. Campieri M, Rizzello F, Venturi A, Poggioli G, Ugolini F. Combination of antibiotic and probiotic treatment is efficacious in prophylaxis of post-operative recurrence of Crohn's disease: a randomized controlled study vs. mesalamine. Gastroenterology. 2000;118:G4179.
20. Prantera C, Scribano ML, Falasco G, Andreoli A, Luzi C. Ineffectiveness of probiotics in preventing recurrence after curative resection for Crohn's disease: a randomized controlled trial with Lactobacillus GG. Gut. 2002;51:405-409.
21. Hart AI, Stagg AJ, Kamm MA. Use of probiotics in the treatment of inflammatory bowel disease. J Clin Gastroenterol. 2003;36: 111-119.
22. rd ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2001:1070-1089.
23. Gionchetti P, Rizzello F, Helwig U, et al. Prophylaxis of pouchitis onset with probiotic therapy: a double-blind, placebo-controlled trial. Gastroenterology. 2003;124:1202-1209.
24. Gionchetti P, Rizzello F, Venturi A, et al. Oral bacteriotherapy as maintenance treatment in patients with chronic, treatment-resistant pouchitis: a double-blind, placebo-controlled trial. Gastroenterology. 2000;119:305-309.
25. Alverdy JC, Laughlin RS, Wu L. Influence of the critically ill state on host-pathogen interactions within the intestine: gut derived sepsis redefined. Crit Care Med. 2003;31:598-607.
26. Bedirli A, Gokahmetoglu S, Sakrak O, Soyuer I, Ince O, Sozuer E. Beneficial effects on recombinant platelet-activating factor acetylhydrolase and BN 52021 on bacterial translocation in cerulein-induced pancreatitis. Eur Surg Res. 2004;36:136-141.
27. Dervenis C, Smailis D, Hatzitheoklitos E. Bacterial translocation and its prevention in acute pancreatitis. J Hepatobil Pancreato Surg. 2003;10:415-418.
28. Luiten EJT, Hop WCJ, Endtz HP, Bruining HA. Prognostic importance of Gram-negative intestinal colonization pancreatic infection in severe acute pancreatitis. Intensive Care Med. 1998; 24:438-445.
29. Bengmark S. In: Shikora SA, Martindale RG, Schwaitzberg SD, eds. Nutritional Considerations in the Intensive Care Unit: Science, Rationale and Practice. Dubuque, IA: Kendall/Hunt; 2002: 365-380.
30. Buchler MW, Gloor B, Muller CA, Friess H, Seiler CA, Uhl W. Acute necrotizing pancreatitis: treatment strategy according to the status of infection. Ann Surg. 2000;232:619-626.
31. Olah B, Belagyi T, Issekutz A, et al. Early enteral nutrition with specific Lactobacillus and fibre reduces sepsis in severe acute pancreatitis. Br J Surg. 2002;89:1103-1107.
32. Mangiante G, Canepari P, Collucci G, et al. A probiotic as an antagonist of bacterial translocation in experimental pancreatitis. Chir Ital. 1999;51:221-226.
33. Wade JJ, Rolando N, Hayllar K, Philpott-Howard J, Casewell MW, Williams R. Bacterial and fungal infections after liver transplantation: an analysis of 284 patients. Hepatology. 1995;21: 1326-1336.
34. Hollenbeck ChS, Alfrey EJ, Souba WW. The effect of surgical site infections on outcomes and resource utilization after liver transplantation. Surgery. 2001;130:388-395.
35. Rayes N, Seehofer D, Theruvath T, et al. Supply of pre- and probiotics reduces bacterial infection rates after liver transplantation - a randomized, double-blind trial. Am J Transplant. 2005; 5:125-130.
36. Rayes N, Hansen S, Seehofer D, et al. Early enteral supply of Lactobacillus and fibre vs. selective bowel decontamination (SBD): a controlled trial in liver transplant recipients. Transplantation. 2002;74:123-127.
37. Jobe BA, Grasley A, Deveney KE, Deveney CW, Sheppard BC. Clostridium difficile colitis: an increasing hospital-acquired illness. Am J Surg. 1995;169:480-483.
38. Elmer GW, McFarland LV. Biotherapeutic agents in the treatment of infectious diarrhea. Gastroenterol Clin North Am. 2001; 30:837-854.
39. Moyenuddin M, Williamson JC, Ohl CA. Clostridium difficile-associated diarrhea: current strategies for diagnosis and therapy. Curr Gastroenterol Rep. 2002;4:279-286.
40. McFarland LV, Surawicz CM, Greenberg RN, et al. A randomized placebo-controlled trial of Saccharomyces boulardii in combination with standard antibiotics for Clostridium difficile disease. JAMA. 1994;271:1913-1918.
41. Surawicz CM, McFarland LV, Greenberg RN, et al. The search for a better treatment for recurrent Clostridium difficile disease: the use of high dose vancomycin combined with Saccharomyces boulardii. Clin Infect Dis. 2000;31:1012-1017.
42. Gorbach SL, Chang T-W, Goldin B. Successful treatment of relapsing Clostridium difficile colitis with Lactobacillus GG. Lancet. 1987;2:1519.
43. Poshapin M. The effect of probiotics on Clostridium difficile diarrhea. Am J Gastroenterol. 2000;95:S11-S13.
44. Surawicz CM, Elmer GW, Speelman P, McFarland LV, Chinn J, van Belle G. Prevention of antibiotic-associated diarrhea by Saccharomyces boulardii: a prospective study. Gastroenterology. 1989;96:981-988.
45. McFarland LV, Surawicz CM, Greenberg RN, et al. Prevention of beta-lactam-associated diarrhea by Saccharomyces boulardii compared with placebo. Am J Gastroenterol. 1995;90:439-448.
46. Arvola T, Laiho K, Torkkeli S, et al. Prophylactic L. rhamnosus GG reduces antibiotic-associated diarrhea in children with respiratory infections: a randomized study. Pediatrics. 1999;104:e64. Available at: http:www.pediatrics. org/cgi/content/full/104/e64. Accessed July 31, 2004.
47. Resta-Lenert S, Barrett KE. Live probiotics protect intestinal epithelial cells from the effects of infection with enteroinvasive Escherichia coli. Gut. 2003;52:988-997.
48. Michail S, Abernathy F. Lactobacillus plantarum reduces the in vitro secretory response of intestinal epithelial cells to enteropathogenic Escherichia coli infection. J Pediatr Gastroenterol Nutr. 2002;35:350-355.
49. Valyshev AV, Elagina NN, Kirillov VA, Kirillov DA, Bukharin OV. Effect of bifidobacteria on the anti-lysozyme activity of enterobacteria. Zh Mikrobiol Epidemiol Immunobiol. 2000;(suppl 4):77-79.
50. Chouraqui JP, Van Egroo LD, Fichot MC. Acidified milk formula supplemented with Bifidobacterium lactis: impact on infant diarrhea in residential care settings. J Pediatr Gastroenterol Nutr. 2004;38:288-292.
51. Costa-Ribeiro H, Ribeiro TC, Mattos AP, et al. Limitations of probiotic therapy in acute, severe dehydrating diarrhea. J Pediatr Gastroenterol Nutr. 2003;36:112-115.
52. Guandalini S, Pensabene L, Zikri MA, et al. Lactobacillus GG administered in oral rehydration solution to children with acute diarrhea: a multicenter European trial. J Pediatr Gastroenterol Nutr. 2000;30:54-60.
53. Cetina-Sauri G, Basto GS. Therapeutic evaluation of Saccharomyces boulardii in children with acute diarrhea. Tribuna Med. 1989;56:111-115.
54. Turchet P, Laurenzano M, Auboiron S, Antoine JM. Effect of fermented milk containing the probiotic Lactobacillus casei DN-114001 on winter infections in free-living elderly subjects: a randomized, controlled pilot study. J Nutr Health Aging. 2003;7: 75-77.
55. Mansour-Ganaei F, Dehbashi N, Yazdanparast K, Shafagi A. Efficacy of Saccharomyces boulardii with antibiotics in acute amoebiasis. World J Gastroenterol. 2003;9:1832-1833.
56. Pickerd N, Tuthill D. Resolution of cryptosporidiosis with probiotic treatment. Postgrad Med J. 2004;80:112-113.
57. Simenhoff ML, Dunn SR, Zollner GP, et al. Biomodulation of the toxic and nutritional effects of small bowel bacterial overgrowth in end-stage kidney disease using freeze-dried Lactobacillus acidophilus. Miner Electrolyte Metab. 1996;22:92-96.
58. Stotzer P, Blomberg P, Henriksson A, Abrahamsson H. Probiotic treatment of small intestinal bacterial overgrowth by Lactobacillus fermentum KLD. Scand J Infect Dis. 1996;28:615-619.
59. Attar A, Flourie B, Rambaud J, Franchisseur C, Ruszniewski P, Bouhnik Y. Antibiotic efficacy in small intestinal bacterial overgrowth-related chronic diarrhea: a crossover, randomized trial. Gastroenterology. 1999;117:794-797.
60. Rayes N, Hansen S, Boucsein K, et al. Early enteral supply of fibre and Lactobacilli vs parenteral nutrition: a controlled trial in major abdominal surgery patients. Nutrition. 2002;18:609-615.
61. McNaught CE, Woodcock NP, MacFie J, Mitchell CJ. A prospective randomized study of the probiotic Lactobacillus plantarum 299V on indices of gut barrier function in elective surgical patients. Gut. 2002;51:827-831.
62. Delzenne N, Cherbut C, Neyrinck A. Prebiotics: actual and potential effects on inflammatory and malignant colonic diseases. Curr Opin Clin Nutr Metab Care. 2003;6:581-586.
63. Miyauchi S, Gopal E, Fei YJ, Ganapathy V. Functional identification of SLC5A8, a tumor suppressor down-regulated in colon cancer, as a Na(+)-coupled transporter for short-chain fatty acids. J Biol Chem. 2004;279:13293-13296.